期刊文献+

霍乱毒素B亚单位胰岛素混合蛋白抗糖尿病作用 被引量:1

Effect of admixture of cholera toxoid B and insulin on spontaneous autoimmune diabetes
下载PDF
导出
摘要 目的观察口服不同剂量霍乱毒紊B亚单位(CrB)与胰岛紊(insulin)混合蛋白疫苗的免疫耐受及预防1型糖尿病作用,为探讨社区糖尿病干预方案提供依据。方法3周龄雌性NOD小鼠60只,随机分为磷酸缓冲液(PBs)阴性对照、1mg胰岛紊阳性对照、CTB+insulin100μg,CTB+insulin 1mg等4组。从4周龄起,每周灌胃2次~12周龄;12周龄起,每周1次动态监测小鼠尿糖、血糖,至26周龄,观察糖尿病的发生,比较各组糖尿病发病率。结果与磷酸缓冲液(PBs)组比较,CTB+insulin100μg。CTB+insulin 1mg能够减少NOD小鼠糖尿病的发生,降低小鼠糖尿病的累积发病率。至鼠龄26周时,PBS组、CTB+insulin100μg,CTB+insulin1mg组和1mg胰岛素组的累积发病率分别为100%,60%,60%和40%,与阴性对照组比较,其他3组的累积发病率差异均有统计学意义(均P〈0.05);2个试验组与阳性对照组的累积生存率及生存分布的差异无统计学意义。结论CTB+insulin混合蛋白疫苗能够降低NOD小鼠糖尿病累积发病率,提高小鼠生存率;CTB+insulin1mg组的预防作用优于100μg组。 Objective To observe the diabetes prevention effects of oral administration of the admixtures of insulin and cholera toxin B subunit(CTB)on female nonobese diabetic mice, and to offer evidence for constructing diabetes administrative project in community. Methods 40 3 - weeks - old female NOD mice were divided randomly into four groups. Oral administration persisted from 4 - weeks - old to 12 - weeks - old. The whole observation lasted to 26 - weeks - old. Glycosuria and glycemia were measured from 12 weeks to 26 weeks. The cumulative incidence rate were compared to estimate the effect of oral administration. Results Oral administration of CTB + insulin 100μg, CTB + insulin lmg and insulin 1mg to female NOD mice significantly suppressed incidence of diabetes than PBS group. The cumulative incidence rate of PBS, CTB + insulin 100 μg, CTB + insulin l mg and insulin 1 mg were 100 %, 60 %, 60 %, 40 % (P 〈 0.05). And two examination groups had no significant difference with the insulin 1mg group. Conclusion Oral administration of CTB + insulin 100 μg, CTB + insulin ling to female NOD mice significantly can suppress incidence of diabetes and enhance the diabetes prevention effect than PBS group.
出处 《中国公共卫生》 CAS CSCD 北大核心 2006年第10期1245-1246,共2页 Chinese Journal of Public Health
基金 国家自然科学基金(30170818)
关键词 霍乱毒素B亚单位 免疫耐受 NOD小鼠 Cholera Toxin B subunit(CTB) immune tolerance nonobese diabetic mice (NOD mice)
  • 相关文献

参考文献4

二级参考文献17

  • 1王姮,李玉秀,孙琦,杨国华.Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans[J].Chinese Medical Journal,2000(5):49-52. 被引量:3
  • 2任宏,欧阳凤秀,姜庆五.口服胰岛素对1型糖尿病小鼠预防与治疗作用[J].中国公共卫生,2004,20(4):397-398. 被引量:2
  • 3[1]Zhang J, Daviadson L, Elisenbarth G, et al. Suppression f diabetic mice by oral administration of porcine insulin[J]. Proc Natl Acad Sci USA, 1991, 88:10252 - 10256.
  • 4[2]Bregenholt S, Wang M, Wolfe T, et al. The cholera toxin B subunit is a numcosal adjuvant for oral tolerance induction in type 1 diabetes [J]. Scand J Immunol, 2003, 57(5) :432 - 438.
  • 5[3]Sadeghi H, Bregenholt S, Wegmann D, et al. Genetic fusion of human insulin B- chain to the B- subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo [ J ]. Imunology, 2002, 106 (2): 237 - 245.
  • 6[4]Aspord C, Thivolet C. Nasal administration of CTB- insulin induces active tolerance against autoimmune diabetes in non- obese diabetic(NOD) mice[J]. Clin Exp Immunol, 2002, 130(2) :204 - 211.
  • 7[5]Hanninen A. Prevention of Autoimmune Type 1 Diabetes via Mucosal Tolerance: Is Mucosal Autoantigen Administration As Safe and Effective As It Should[J ]. Scand J Immunol, 2000, 52: 217 -225.
  • 8[6]Liu E, Moriyama H, Abiru N, et al. Anti - peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self - peptides B: 9 - 23 and B: 13 - 23 [ J ]. J Clin Invest, 2002, 110 ( 7 ):1021 - 1027.
  • 9Zhang Z J,Proc Natl Acad Sci USA,1991年,88卷,10252页
  • 10Y. Takeda,M. Gotoh,K. Dono,M. Nishihara,T. Grochowiecki,F. Kimura,T. Yoshida,Y. Ohta,H. Ota,H. Ohzato,K. Umeshita,T. Takeda,N. Matsuura,M. Sakon,N. Kayagaki,H. Yagita,K. Okumura,M. Miyasaka,M. Monden.Protection of islet allografts transplanted together with Fas ligand expressing testicular allografts[J]. Diabetologia . 1998 (3)

共引文献2

同被引文献9

  • 1刘吏婷,江海燕,颜艳,崔平,王希良,王建华.以霍乱毒素重组B亚单位为佐剂的流感抗原滴鼻免疫效果研究[J].西北农业学报,2007,16(4):202-205. 被引量:3
  • 2Schulze K, Medina E, Talay SR, et al. Characterization of the domain of fibronectin-binding protein I of Streptococcus pyogenes responsible for elicitation of a protective immune response. Infect Immun, 2001, 69(1): 622-5
  • 3Pizza M, Giuliani M, Fontana M, et al. Mucosal vaccines: nontoxic derivatives of L T and CT as mucosal adjuvants. Vaccine, 2001, 19(17-19): 2534-41
  • 4Sun JB, Raghavan S, Sjoling A, et al. Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3^+ CD25^+ and Foxp3- CD25^- CD4^+ regulatory T cells. J Immunol, 2006, 177(11): 7634-44
  • 5Tamura S, Funato H, Hirabayashi Y, et al. Functional role of respiratory tractheamaglutin-spectific IgA antibodies in protection against influenza. Vaccine, 1990, 8(5): 479-85
  • 6Luci C, Hervouet C, Rousseau D, et al. Dendritic cell-mediated induction of mucosal cytotoxic responses following intravaginal immunization with the nontoxic B subunit of cholera toxin. J Immunol, 2006, 176(5): 2749-57
  • 7Coccia EM, Remoli ME, Giacinto CD. Cholera toxin subunit B inhibits IL-12 and IFN-γ production and signaling in experimental colitis and Crohn's disease. Gut, 2005, 54: 1558-64
  • 8Isaka M, Komiya T, Takahashi M, et al. Recombinant cholera toxin B subunit (rCTB) as a mucosal adjuvant enhances induction of diphtheria and tetanus antitoxin antibodies in mice by intranasal administration with diphtheria-pertussis-tetanus (DPT) combination vaccine. Vaccine, 2004, 22 (23-24): 3061-8
  • 9Holmgren J, Adamsson J, Clemens, J, et al. Mucosal adjuvants and antiinfection and antiimmunopat-hology vaccines based on cholera toxin, cholera toxin B subunit and Cp G DNA. Immunol Lett, 2005, 97(2): 181-8

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部